dorsaVi (ASX: DVL) has taken a significant step toward the next generation of intelligent wearables and robotics with the acquisition of a neuromorphic technology portfolio from researchers at Technion – Israel Institute of Technology, led by Professor Shahar Kvatinsky, a global authority in Processing-in-Memory and adaptive hardware systems. …
dorsaVi secures breakthrough neuromorphic technology to power next-generation wearables and robotics
November 12, 2025 Australian Biotech
Latest Video
New Stories
-
Patients and clinicians defend MS treatment choice during review stakeholder meeting
November 5, 2026 - - Latest News -
Vaccines dominate public health spending but prevention investment slips
November 5, 2026 - - Latest News -
Increased accountability can be the only response to expanding authority
November 5, 2026 - - Latest News -
Sydney summit program focused on the reshaping power of AI
November 4, 2026 - - Latest News -
Is the reluctance to revisit term limits because they are such an obvious change?
November 4, 2026 - - Latest News -
Does new report suggest that patient voice reforms are stalling?
November 4, 2026 - - Latest News -
Medicines industry faces tough PBS talks, but will it be the most challenging ever?
November 3, 2026 - - Latest News